These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 37505499
1. Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules. Fu G, Chazen RS, Monteiro E, Vescan A, Freeman JL, Witterick IJ, MacMillan C. JAMA Netw Open; 2023 Jul 03; 6(7):e2323500. PubMed ID: 37505499 [Abstract] [Full Text] [Related]
2. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of Thyroid Cancer. Fu G, Chazen RS, MacMillan C, Witterick IJ. JAMA Netw Open; 2024 May 01; 7(5):e2411919. PubMed ID: 38758552 [Abstract] [Full Text] [Related]
4. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population. Lee SE, Hwang TS, Choi YL, Han HS, Kim WS, Jang MH, Kim SK, Yang JH. Thyroid; 2016 Jul 01; 26(7):901-10. PubMed ID: 27184112 [Abstract] [Full Text] [Related]
17. Clinical Utility of BRAF, NRAS, and TERT Promoter Mutation in Preoperative Thyroid Fine-Needle Aspiration Biopsy: A Diagnostic Study From Dharmais Cancer Hospital. Perdana AB, Putri RI, Rachmawati R, Andinata B, Brahma B. Asian Pac J Cancer Prev; 2020 Nov 01; 21(11):3267-3277. PubMed ID: 33247684 [Abstract] [Full Text] [Related]
18. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules. Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Šeinin D, Šileikytė A, Strupas K. Exp Clin Endocrinol Diabetes; 2019 Apr 01; 127(4):247-254. PubMed ID: 29566402 [Abstract] [Full Text] [Related]
19. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules. Li X, Du H, Luo J, Ding W, Lai B, He J, Xu S, Zhang Y. J Clin Lab Anal; 2020 Nov 01; 34(11):e23458. PubMed ID: 32671901 [Abstract] [Full Text] [Related]
20. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J. J Clin Oncol; 2014 Sep 01; 32(25):2718-26. PubMed ID: 25024077 [Abstract] [Full Text] [Related] Page: [Next] [New Search]